Skip to main content
Clinical Trials/NCT01249768
NCT01249768
Unknown
Not Applicable

Observational Study Assessing the Diagnostic Contribution of 3-Tesla MRI, CSF Analysis and a Second Opinion in a Specialized Movement Disorder Centre, in Differentiating Between Parkinson's Disease and Atypical Parkinsonism

Radboud University Medical Center1 site in 1 country150 target enrollmentJuly 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Radboud University Medical Center
Enrollment
150
Locations
1
Primary Endpoint
percentage of correct diagnosis for each of the specified ancillary investigations
Last Updated
10 years ago

Overview

Brief Summary

Background:

Parkinson's Disease and the Atypical Parkinsonian Disorder (like Multiple System Atrophy, Progressive Supranuclear Palsy, Corticobasal Degeneration, Lewy Body Dementia) are disease entities with partly common symptomatology. Especially very early in the course of disease, the differentiation between both disease entities can be challenging, even for specialists in the field of movement disorder. However, the establishment of a correct diagnosis is very important for adequate patientcounseling, treatment and the correct inclusion of patients in research trials. Ancillary diagnostic investigations are looked upon to aid in this diagnostic dilemma.

Objective:

To investigate the value of ancillary diagnostic investigations, more specific MRI, analysis of cerebrospinal fluids and a second opinion in a specialized movement disorder centre, to differentiate Parkinson's disease and the Atypical Parkisonisonian disorder.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
July 2018
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marjolein Aerts

dr. M.B. Aerts

Radboud University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Hypokinetic rigid syndrome
  • Disease duration of maximum 36 months

Exclusion Criteria

  • Probable diagnosis of PD without any red flags
  • Probable diagnosis MSA
  • Probable diagnosis PSP
  • Diagnosis CBD
  • Diagnosis DLB
  • Probable diagnosis Vascular Parkinsonism
  • Other neurodegenerative disease than parkinsonism
  • A prior history of brain surgery
  • Instable comorbidity

Outcomes

Primary Outcomes

percentage of correct diagnosis for each of the specified ancillary investigations

Time Frame: 36 months

Percentage of correct diagnosis for each of the specified ancillary investigations to differentiate between either PD or atypical parkinsonism

Secondary Outcomes

  • Percentage of correct diagnosis for each of the specified ancillary investigations(36 months)

Study Sites (1)

Loading locations...

Similar Trials